CS
NUVA

Credit Suisse’s NuVasive, Inc. NUVA Stock Holding History

Credit Suisse’s Portfolio NUVA Stock Details NUVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-102,744
Closed -$4.27M – 3199
2023
Q2 		$4.27M Sell
102,744
-45,673
-31% -$1.88M ﹤0.01% 1440
2023
Q1 		$6.13M Buy
148,417
+58,215
+65% +$2.49M 0.01% 1178
2022
Q4 		$3.72M Buy
90,202
+14,677
+19% +$594K ﹤0.01% 1491
2022
Q3 		$3.31M Buy
75,525
+2,545
+3% +$123K ﹤0.01% 1511
2022
Q2 		$3.59M Sell
72,980
-1,794
-2% -$96.2K ﹤0.01% 1518
2022
Q1 		$4.24M Buy
74,774
+1,503
+2% +$79.8K ﹤0.01% 1576
2021
Q4 		$3.85M Sell
73,271
-3,593
-5% -$195K ﹤0.01% 2242
2021
Q3 		$4.6M Buy
76,864
+3,556
+5% +$219K ﹤0.01% 2132
2021
Q2 		$4.97M Sell
73,308
-2,248
-3% -$153K ﹤0.01% 2089
2021
Q1 		$4.95M Sell
75,556
-19,959
-21% -$1.2M ﹤0.01% 2073
2020
Q4 		$5.38M Sell
95,515
-92,225
-49% -$4.54M ﹤0.01% 2037
2020
Q3 		$9.12M Buy
187,740
+127,944
+214% +$6.89M 0.01% 1422
2020
Q2 		$3.33M Buy
59,796
+18,570
+45% +$1.07M ﹤0.01% 1989
2020
Q1 		$2.09M Sell
41,226
-3,456
-8% -$232K ﹤0.01% 2109
2019
Q4 		$3.46M Buy
44,682
+4,973
+13% +$351K ﹤0.01% 2167
2019
Q3 		$2.52M Sell
39,709
-2,752
-6% -$172K ﹤0.01% 2300
2019
Q2 		$2.49M Sell
42,461
-10,577
-20% -$624K ﹤0.01% 2295
2019
Q1 		$3.01M Buy
53,038
+8,431
+19% +$448K ﹤0.01% 2077
2018
Q4 		$2.21M Buy
44,607
+1,499
+3% +$90.2K ﹤0.01% 2163
2018
Q3 		$3.06M Sell
43,108
-13,269
-24% -$844K ﹤0.01% 2035
2018
Q2 		$2.94M Sell
56,377
-950
-2% -$49.8K ﹤0.01% 2138
2018
Q1 		$2.99M Sell
57,327
-28,441
-33% -$1.44M ﹤0.01% 2095
2017
Q4 		$5.02M Sell
85,768
-35,128
-29% -$1.99M ﹤0.01% 1784
2017
Q3 		$6.71M Buy
120,896
+52,550
+77% +$3.48M 0.01% 1527
2017
Q2 		$5.26M Buy
68,346
+21,410
+46% +$1.6M 0.01% 1594
2017
Q1 		$3.5M Sell
46,936
-12,661
-21% -$919K ﹤0.01% 1910
2016
Q4 		$4.01M Sell
59,597
-4,582
-7% -$295K ﹤0.01% 1818
2016
Q3 		$4.28M Buy
64,179
+8,773
+16% +$559K ﹤0.01% 1794
2016
Q2 		$3.31M Buy
55,406
+25,705
+87% +$1.39M ﹤0.01% 1951
2016
Q1 		$1.45M Sell
29,701
-11,963
-29% -$543K ﹤0.01% 2443
2015
Q4 		$2.25M Buy
41,664
+6,283
+18% +$320K ﹤0.01% 2198
2015
Q3 		$1.71M Sell
35,381
-1,359
-4% -$70.2K ﹤0.01% 2373
2015
Q2 		$1.74M Buy
36,740
+623
+2% +$29.1K ﹤0.01% 2662
2015
Q1 		$1.66M Sell
36,117
-3,130
-8% -$145K ﹤0.01% 2546
2014
Q4 		$1.85M Sell
39,247
-32,341
-45% -$1.35M ﹤0.01% 2599
2014
Q3 		$2.5M Sell
71,588
-2,830
-4% -$101K ﹤0.01% 2316
2014
Q2 		$2.65M Buy
74,418
+36,980
+99% +$1.27M ﹤0.01% 2477
2014
Q1 		$1.44M Sell
37,438
-58,620
-61% -$2.15M ﹤0.01% 2800
2013
Q4 		$3.11M Buy
96,058
+52,452
+120% +$1.58M ﹤0.01% 2258
2013
Q3 		$1.07M Sell
43,606
-6,403
-13% -$158K ﹤0.01% 2900
2013
Q2 		$1.24M Buy
+50,009
New +$1.09M ﹤0.01% 2630

Other funds holding NUVA

IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
BTI
Blue Trust Inc Alpharetta, Georgia $9.54B AUM 19.86% 1-Year Est. Return

Credit Suisse's NUVA Position: Q3 2023 in Review

Credit Suisse sold out of NuVasive, Inc. (NUVA) in Q3 2023, closing a stake of 102,744 shares — an estimated $4.27M sold.

Credit Suisse first reported a position in NUVA in Q2 2013 and held it in 41 quarters. The position peaked at $9.12M in Q3 2020. 2 funds tracked by Wall St. Rank hold NUVA as of Q3 2023.

  • Credit Suisse reported no remaining NuVasive, Inc. position as of Q3 2023 after selling out during the quarter.
  • Credit Suisse sold 102,744 NuVasive, Inc. shares in Q3 2023, an estimated $4.27M.
  • Credit Suisse first reported a position in NuVasive, Inc. in Q2 2013 and held it in 41 quarters.
  • Credit Suisse's NuVasive, Inc. position peaked at $9.12M in Q3 2020.
  • 2 funds tracked by Wall St. Rank held NuVasive, Inc. as of Q3 2023.

Based on Credit Suisse's 13F filing for Q3 2023, filed 13 Nov 2023.